Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-019599
Filing Date
2013-04-02
Accepted
2013-04-02 16:22:11
Documents
1
Period of Report
2013-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4227
  Complete submission text file 0001209191-13-019599.txt   5591
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
GOLDSTEIN ALLAN L (Reporting) CIK: 0000905390 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 13735650